ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2024 | $117,694 | Replaced |
| 2nd Quarter - Amendment (this page) | Mar 6, 2025 | $120,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER New | — |
| MICHAEL WARD | — |
Medicare/Medicaid MMM
-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Beneficiary access to diabetes management devices -Vaccine access issues -White House Initiative on Womens Health Research
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER | — |
| MICHAEL WARD | — |
Budget/Appropriations BUD
-FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -FY25 report language for the Medicare Prescription Payment Plan
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER | — |
| MICHAEL WARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.